Research Interests
Neurosciences Ageing, Frailty and Mobility Neuroscience, Behaviour and Brain HealthMiss Laura Carr
Research Assistant
School of Pharmacy and Biomedical Sciences
College of Health
After completing an Bachelor of Psychological Science at the University of Adelaide, Laura went on to complete an Honours year and PhD working in the Cognition, Ageing and Neurodegenerative Disease Laboratory (CANDL) under the supervision of A/Prof Lyndsey Collins-Praino, graduating in 2025.
Laura is currently working part time at CANDL focusing on investigating risk factors for neurodegenerative diseases, specifically on how molecular changes induced by these risk factors may influence susceptibility to neurodegenerative processes. She is primarily interested in investigating the role that inflammatory mechanisms play in processes such as brain ageing, traumatic brain injury and viral infections, and hopes to gain an understanding of how the brain’s immune system can be targeted to promote healthy ageing and improve outcomes for neurodegenerative conditions.
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2021 - 2025 | University of Adelaide | Australia | PhD |
| 2020 - 2020 | The University of Adelaide | Australia | Bachelor of Health and Medical Science (Honours) |
| 2017 - 2019 | The University of Adelaide | Australia | Bachelor of Psychological Science |
| Year | Citation |
|---|---|
| 2026 | Carr, L. M., Guglietti, B., Wee, I. C., Musgrave, I. F., Mustafa, S., Corrigan, F., & Collins-Praino, L. E. (2026). Comparison of automated and manual approaches for microglial quantification and classification: A focus on the HALO digital pathology platform. Brain Pathology, 36(1), 17 pages. Europe PMC1 |
| 2025 | Carr, L., Mustafa, S., & Collins-Praino, L. E. (2025). The Hallmarks of Ageing in Microglia. Cellular and Molecular Neurobiology, 45(1), 38 pages. Scopus11 WoS11 Europe PMC11 |
| 2024 | Carr, L. M., Mustafa, S., Care, A., & Collins-Praino, L. E. (2024). More than a number: Incorporating the aged phenotype to improve in vitro and in vivo modeling of neurodegenerative disease. Brain, Behavior, and Immunity, 119, 554-571. Scopus2 WoS2 Europe PMC2 |
| 2024 | Green, A. L., Cowell, E. C., Carr, L. M., Hemsley, K., Sherratt, E., Collins-Praino, L. E., & Carr, J. M. (2024). Application of diceCT to Study the Development of the Zika Virus-Infected Mouse Brain. Viruses, 16(8), 1330-1-1330-19. Scopus1 WoS1 |
| 2021 | Guglietti, B., Carr, L., Ellul, B., Mustafa, S., Corrigan, F., & Collins-Praino, L. (2021). Fyn kinase inhibition using AZD0530 improves recognition memory and reduces depressive-like behaviour in an experimental model of Parkinson’s disease. Europe PMC1 |
| Year | Citation |
|---|---|
| 2024 | Green, A., Cowell, E., Carr, L., Hemsley, K., Sherratt, E., Collins-Praino, L., & Carr, J. (2024). Application of diceCT to Study the Development of the Zika Virus Infected Mouse Brain. DOI |
Practical demonstrator
Foundations of Human Neuroanatomy (ANAT SC 2006), Semester 1, 2021/2022
Tutor
Essentials of Neuroscience (HLTH SC 1001), Semester 2, 2021
Connect With Me
External Profiles
